var data={"title":"Mebendazole: Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Mebendazole: Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6511?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=mebendazole-drug-information\" class=\"drug drug_general\">see &quot;Mebendazole: Drug information&quot;</a> and <a href=\"topic.htm?path=mebendazole-patient-drug-information\" class=\"drug drug_patient\">see &quot;Mebendazole: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46303332\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Emverm</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191554\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Vermox</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048400\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Anthelmintic</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048395\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=mebendazole-drug-information\" class=\"drug drug_general\">see &quot;Mebendazole: Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>\n        <i>Ancylostoma duodenale</i> or <i>Necator americanus</i> (hookworm):</b> Children and Adolescents (Limited data in children &lt;2 years): Oral: 100 mg twice daily for 3 days or 500 mg once as a single dose; repeat in 3 weeks if not cured with initial treatment (CDC 2013a; <i>Red Book</i> [AAP 2015])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Ascariasis (roundworm):</b> Children and Adolescents (Limited data in children &lt; 2 years): Oral: 100 mg twice daily for 3 days or 500 mg once as a single dose; repeat in 3 weeks if not cured with initial treatment (CDC 2013b; <i>Red Book</i> [AAP 2015])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Capillariasis:</b> Limited data available: Children and Adolescents: Oral: 200 mg twice daily for 20 days (CDC 2012a; <i>Red Book</i> [AAP 2015])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Enterobiasis (pinworm):</b> Children and Adolescents (Limited data in children &lt;2 years): Oral: 100 mg as a single dose, repeat in 2 to 3 weeks if not cured with initial treatment (CDC 2016; <i>Red Book</i> [AAP 2015]).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Toxocariasis (roundworm, ocular larva migrans, visceral larva migrans):</b> Limited data available: Children and Adolescents: Oral: 100 to 200 mg twice daily for 5 days (CDC 2013c; <i>Red Book</i> [AAP 2015])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Trichinellosis (trichinosis; <i>Trichinella</i> species):</b> Limited data available: Children and Adolescents: Oral:  200 to 400 mg 3 times daily for 3 days, then 400 to 500 mg 3 times daily for 10 days (CDC 2012b; <i>Red Book</i> [AAP 2015])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Trichuriasis (whipworm):</b> Children and Adolescents (Limited data in children &lt;2 years): Oral: 100 mg twice daily for 3 days; repeat in 3 weeks if not cured with initial treatment (CDC 2013d; <i>Red Book</i> [AAP 2015]).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>\n        <i>Ancylostoma duodenale</i> or <i>Necator americanus</i> (hookworm):</b> Oral: 100 mg twice daily for 3 days; repeat in 3 weeks if not cured with initial treatment</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Ascariasis (roundworm):</b> Oral: 100 mg twice daily for 3 days; repeat in 3 weeks if not cured with initial treatment</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Enterobiasis (pinworm):</b> Oral: 100 mg as a single dose, repeat in 3 weeks if not cured with initial treatment</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Trichuriasis (whipworm):</b> Oral: 100 mg twice daily for 3 days; repeat in 3 weeks if not cured with initial treatment</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in renal impairment:</b> There are no dosage adjustments provided in the manufacturer's labeling; not removed by hemodialysis (Allgayer 1984).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in hepatic impairment:</b> There are no dosage adjustments provided in the manufacturer's labeling; however, undergoes extensive hepatic metabolism; use with caution as systemic exposure may be increased.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46303333\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet Chewable, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Emverm: 100 mg [contains corn starch, fd&amp;c yellow #6 (sunset yellow), saccharin sodium]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20452591\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F49296536\" class=\"block accres drugH1Div\"><span class=\"drugH1\">Prescribing and Access Restrictions</span>\n    <p style=\"text-indent:0em;display:inline\">Vermox 500 mg chewable tablets are only available through Johnson &amp; Johnson's Vermox Donation Program to help reduce the burden of soil-transmitted helminths in endemic countries. There are currently no plans to make Vermox 500 mg chewable tablets commercially available.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048403\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Oral: Administer with or without  food; tablet can be crushed and mixed with food, swallowed whole, or chewed </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F11232835\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:0em;display:inline\">Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048402\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Treatment of <i>Ancylostoma duodenale</i> or <i>Necator americanus</i> (hookworms), <i>Ascaris lumbricoides</i> (roundworms), <i>Enterobius vermicularis</i> (pinworms), and <i>Trichuris trichiura</i> (whipworms) in single or mixed infections (FDA approved in ages &ge;2 years and adults). Has also been used in the treatment of <i>Capillaria philippinensis</i> (capillariasis), <i>Trichinella</i> species (Trichinellosis), and visceral larva migrans (toxocariasis)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9500697\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Mebendazole may be confused with metroNIDAZOLE</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191603\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Abdominal pain, anorexia, diarrhea, flatulence, nausea, vomiting</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hepatic: Hepatitis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rare but important or life-threatening: Abnormal hepatic function tests, agranulocytosis, alopecia, anaphylaxis, angioedema, decreased ejaculate volume (Parasitic Infections 2013), dizziness, glomerulonephritis, hepatitis, hypersensitivity reaction, leukopenia (Parasitic Infections 2013), neutropenia, seizure, skin rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191537\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to mebendazole or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191523\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Bone marrow suppression: Neutropenia and agranulocytosis have been reported with high doses and prolonged use. Monitor CBC if used at higher doses or for a prolonged duration.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hepatic impairment: Use with caution; systemic exposure may be increased with hepatic impairment.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric: Experience with use in children &lt;2 years of age is limited; convulsions have been reported postmarketing in pediatric patients &lt;1 year.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299650\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191528\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=12571&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Aminoquinolines (Antimalarial): May decrease the serum concentration of Anthelmintics.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">CarBAMazepine: May decrease the serum concentration of Mebendazole.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cimetidine: May increase the serum concentration of Mebendazole.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Fosphenytoin: May decrease the serum concentration of Mebendazole.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">MetroNIDAZOLE (Systemic): Mebendazole may enhance the adverse/toxic effect of MetroNIDAZOLE (Systemic). Particularly the risk for Stevens-Johnson syndrome or toxic epidermal necrolysis may be increased. <i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Phenytoin: May decrease the serum concentration of Mebendazole.<i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191549\" class=\"block foi drugH1Div\"><span class=\"drugH1\">Food Interactions</span>\n    <p style=\"text-indent:0em;display:inline\">Mebendazole serum levels may be increased if taken with food. Management: Administer without regard to meals.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13386518\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Untreated soil transmitted helminth infections during pregnancy are associated with adverse outcomes (eg, maternal iron deficiency anemia, low birth weight, neonatal and maternal death). Treatment of pinworm in pregnancy with mebendazole may be considered; however, the CDC suggests postponing therapy until the third trimester when possible (CDC 2016a).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048399\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Periodic hematologic, hepatic, and renal function; check for helminth ova in feces within 3 to 4 weeks following the initial therapy</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191522\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Inhibits the formation of helminth microtubules; selectively and irreversibly blocks glucose uptake and other nutrients in susceptible adult intestine-dwelling helminths</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191536\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Absorption: Oral: Poor; 5% to 10%; increased with food (Dayan 2003)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Distribution: V<sub>d</sub>: 1 to 2 L/kg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Protein binding: 90% to 95%</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metabolism: Extensively hepatic</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Half-life elimination: 3 to 6 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: Primarily feces (as unchanged drug and primary metabolite); urine (&lt;2%)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46312663\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Emverm Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100 mg (1): $442.80</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F191542\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Adec (TW);</li>\n      <li>Anelmin (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Antiox (PH);</li>\n      <li>Astazole (ET);</li>\n      <li>Azoel (PY);</li>\n      <li>Benda (TH, VN);</li>\n      <li>Bendazole (JO);</li>\n      <li>Benhol (LK);</li>\n      <li>Big-Ben (TH);</li>\n      <li>Combantrin-1 (NZ);</li>\n      <li>Combantrin-1 with mebendazole (AU);</li>\n      <li>Conquer (TW);</li>\n      <li>Cremox (BD);</li>\n      <li>D-Worm (ZA);</li>\n      <li>Daxol (PY);</li>\n      <li>Diacor (CL);</li>\n      <li>Diazolen (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Endal (LK);</li>\n      <li>Fugacar (TH, VN);</li>\n      <li>Helben (BD);</li>\n      <li>Hitolin (TW);</li>\n      <li>Kaizole (TW);</li>\n      <li>L-Ombrix (MX);</li>\n      <li>Lomper (ES);</li>\n      <li>Madnil (BD);</li>\n      <li>Mebedal (MX);</li>\n      <li>Mebendazol (MX);</li>\n      <li>Mebensole (MX);</li>\n      <li>Mebex (ET, IN);</li>\n      <li>Mebez (ET);</li>\n      <li>Mebezol (TW);</li>\n      <li>Mebzol (AE, BH, KW, QA);</li>\n      <li>Nemasole (AR);</li>\n      <li>Pantelmin (AT, BR, CO, EC, PE, PT, PY, UY, VE);</li>\n      <li>Quemox (ET, MY, TH);</li>\n      <li>Revapol (MX);</li>\n      <li>Ribamox (BD);</li>\n      <li>Ridworm (AU);</li>\n      <li>Surfont (DE);</li>\n      <li>Thelmox (ET);</li>\n      <li>Toloxim (PT);</li>\n      <li>Vermazol (TR);</li>\n      <li>Vermicol (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Vermid (KR);</li>\n      <li>Vermin-Dazol (MX);</li>\n      <li>Vermoks (UA);</li>\n      <li>Vermox (AE, AU, BB, BE, BF, BG, BH, BJ, BM, BS, BZ, CH, CI, CN, CR, CY, CZ, DE, DK, DO, EE, EG, ET, GB, GH, GM, GN, GR, GT, GY, HK, HN, HR, HU, ID, IE, IL, IQ, IR, IS, IT, JM, JO, KE, KW, LB, LK, LR, LT, LU, LV, LY, MA, ML, MR, MT, MU, MW, MX, NE, NG, NI, NL, NO, NZ, OM, PA, PK, PL, PR, QA, RO, RU, SA, SC, SD, SE, SI, SK, SL, SN, SR, SV, SY, TN, TR, TT, TZ, UG, YE, ZA, ZM, ZW);</li>\n      <li>Vertizole (MX);</li>\n      <li>Warca (TH);</li>\n      <li>Wormazol (AE, BH, QA, SA);</li>\n      <li>Wormgo (ZA);</li>\n      <li>Wormin (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, IN, IQ, IR, JO, KE, KW, LB, LK, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, QA, SA, SC, SD, SL, SN, SY, TN, TZ, UG, YE, ZM, ZW);</li>\n      <li>Wormizol (LK);</li>\n      <li>Zadomen (MY)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Allgayer H, Z&auml;hringer J, Bach P, Bircher J. Lack of effect of haemodialysis on mebendazole kinetics: studies in a patient with echinococcosis and renal failure. <i>Eur J Clin Pharmacol</i>. 1984;27(2):243-245.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-pediatric-drug-information/abstract-text/6499904 /pubmed\" target=\"_blank\" id=\"6499904 \">6499904 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics (AAP). In: Kimberlin DW, Brady MT, Jackson MA, Long SA, eds. <i>Red Book: 2015 Report of the Committee on Infectious Diseases</i>. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). Capillariasis (also known as <i>Capillaria</i> infection). 2012a. Available at <a href=\"http://www.cdc.gov/parasites/capillaria/health_professionals/index.html\" target=\"_blank\">http://www.cdc.gov/parasites/capillaria/health_professionals/index.html</a></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). Parasites - ascariasis. 2013b. Available at <a href=\"http://www.cdc.gov/parasites/ascariasis/health_professionals/index.html\" target=\"_blank\">http://www.cdc.gov/parasites/ascariasis/health_professionals/index.html</a></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). Parasites - enterobiasis (also known as pinworm infection). 2016. Available at <a href=\"http://www.cdc.gov/parasites/pinworm/health_professionals/index.html\" target=\"_blank\">http://www.cdc.gov/parasites/pinworm/health_professionals/index.html</a>. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). Parasites - hookworm. 2013a. Available at <a href=\"http://www.cdc.gov/parasites/hookworm/\" target=\"_blank\">http://www.cdc.gov/parasites/hookworm/</a></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). Parasites - trichuriasis (also known as whipworm infection). 2013d. Available at <a href=\"http://www.cdc.gov/parasites/whipworm/health_professionals/index.html\" target=\"_blank\">http://www.cdc.gov/parasites/whipworm/health_professionals/index.html</a></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). Parasites - trichinellosis (also known as Trichonosis). 2012b. Available at <a href=\"http://www.cdc.gov/parasites/trichinellosis/health_professionals/index.html\" target=\"_blank\">http://www.cdc.gov/parasites/trichinellosis/health_professionals/index.html</a></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). Parasites - toxocariasis (also known as roundworm infection). 2013c. Available at <a href=\"http://www.cdc.gov/parasites/toxocariasis/health_professionals/index.html\" target=\"_blank\">http://www.cdc.gov/parasites/toxocariasis/health_professionals/index.html</a></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Diav-Citrin O, Shechtman S, Arnon J, et al, &quot;Pregnancy Outcome After Gestational Exposure to Mebendazole: A Prospective Controlled Cohort Study,&quot; <i>Am J Obstet Gynecol</i>, 2003, 188(1):282-5.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-pediatric-drug-information/abstract-text/12548230/pubmed\" target=\"_blank\" id=\"12548230\">12548230</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Emverm tablet (mebendazole) [prescribing information]. Horsham PA: Amedra Pharmaceuticals LLC; July 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Gyorkos TW, Larocque R, Casapia M, et al, &quot;Lack of Risk of Adverse Birth Outcomes After Deworming in Pregnant Women,&quot; <i>Pediatr Infect Dis J</i>, 2006, 25(9):791-4.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/mebendazole-pediatric-drug-information/abstract-text/16940835/pubmed\" target=\"_blank\" id=\"16940835\">16940835</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 12571 Version 104.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F46303332\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F191554\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1048400\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1048395\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F46303333\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F20452591\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Prescribing and Access Restrictions\" href=\"#F49296536\" class=\"outlineLink\">Prescribing and Access Restrictions</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1048403\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F11232835\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1048402\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F9500697\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F191603\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F191537\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F191523\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299650\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F191528\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Food Interactions\" href=\"#F191549\" class=\"outlineLink\">Food Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F13386518\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F1048399\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F191522\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F191536\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F46312663\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F191542\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/12571|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=mebendazole-drug-information\" class=\"drug drug_general\">Mebendazole: Drug information</a></li><li><a href=\"topic.htm?path=mebendazole-patient-drug-information\" class=\"drug drug_patient\">Mebendazole: Patient drug information</a></li></ul></div></div>","javascript":null}